Aptose Biosciences Inc (NASDAQ:APTO)
| 0.8334 Delayed Data As of Jun 24 |  +0.0307 / +3.82%Today’s Change | 0.77 Today|||52-Week Range 3.49 | -38.27% Year-to-Date |
Latest APTO News | Press Releases
No recent news for Aptose Biosciences Inc.
Today’s Trading
| Previous close | 0.80 |
| Today’s open | 0.82 |
| Day’s range | 0.82 - 0.85 |
| Volume | 5,639 |
| Average volume (3 months) | 387,928 |
| Market cap | $78.5M |
Data as of 3:59pm ET, 06/24/2022
Growth & Valuation
| Earnings growth (last year) | -8.68% |
| Earnings growth (this year) | +25.05% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.06 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SYBXSynlogic Inc | -0.03 | -2.61% |
| MGTAMagenta Therapeutics... | -0.15 | -10.56% |
| CRTXCortexyme Inc | -0.08 | -3.38% |
| ---- |
Data as of 4:00pm ET, 06/24/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$65.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Toronto, Ontario |
Forecasts
